Danielle Holland
Consejero General en AVEO PHARMACEUTICALS, INC. .
Origen de la red de primer grado Danielle Holland.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 12 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Danielle Holland a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Corporate Officer/Principal | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| HORIZON DISCOVERY GROUP PLC | Medical Specialties | Chief Operating Officer | |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Chief Operating Officer | |
| Worcester Polytechnic Institute | College/University | Undergraduate Degree | |
Enzyvant Therapeutics, Inc.
 Enzyvant Therapeutics, Inc. BiotechnologyHealth Technology Enzyvant Therapeutics, Inc. develops biopharmaceutical products. It focuses on developing transformative therapies for rare diseases with high unmet needs. The company is headquartered in Cambridge, MA. | Biotechnology | Chief Operating Officer | |
| University of San Francisco School of Management | College/University | Masters Business Admin | |
| Clark Atlanta University | College/University | Undergraduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | General Counsel | |
| Harvard Law School | College/University | Graduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree | |
Hogan Lovells US LLP
 Hogan Lovells US LLP Miscellaneous Commercial ServicesCommercial Services Hogan Lovells US LLP provides legal services. The firm’s clients include corporations, financial institutions, and governments. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| ARGENX SE | Pharmaceuticals: Other | Corporate Officer/Principal | |
| Florida State University | College/University | Undergraduate Degree | |
| Assumption College | College/University | Undergraduate Degree | |
| VERASTEM, INC. | Biotechnology | Corporate Officer/Principal | |
| St. Lawrence University | College/University | Undergraduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| Mendoza College of Business | College/University | Masters Business Admin | |
| IMV INC. | Biotechnology | Chairman | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Temple University (Pennsylvania) | College/University | Undergraduate Degree | |
| Brandeis University | College/University | Doctorate Degree | |
| University of Massachusetts | College/University | Graduate Degree | |
| EISAI CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Veranova LP | Corporate Officer/Principal | ||
| MERSANA THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Enzyvant, Inc.
 Enzyvant, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Enzyvant, Inc. develops biopharmaceutical products. The company is based in Cambridge, MA. William T. Symonds has been the CEO of the company since 2022. | Pharmaceuticals: Major | Chief Operating Officer |
Estadísticas
Internacional
| Estados Unidos | 30 |
| Reino Unido | 2 |
| Países Bajos | 2 |
| Canadá | 2 |
| Japón | 2 |
Sectorial
| Health Technology | 21 |
| Consumer Services | 13 |
| Commercial Services | 2 |
Operativa
| Corporate Officer/Principal | 16 |
| Undergraduate Degree | 7 |
| Chief Operating Officer | 7 |
| Director/Board Member | 4 |
| Sales & Marketing | 3 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Danielle Holland
- Conexiones Empresas
